View Clinical Trial (Medical Research Study)

A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-Cell or Follicular Non-Hodgkin's Lymphoma (RATE) - NCT00719472-49048(Clinical Trial 232184)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Kalamazoo
State:  
MI
Zip Code: 49048
Conditions: Non-Hodgkin's Lymphoma
Purpose: This is a prospective, open-label, Phase III, multicenter, single-arm trial designed to assess the safety, pharmacokinetics, and pharmacodynamics of an alternative dosing rate of rituximab in previously untreated patients with DLBCL and follicular NHL. Approximately 385 patients will be enrolled at approximately 100 centers in the United States in order to achieve at least 350 evaluable patients.
Study summary:
Criteria: Inclusion Criteria: - Written informed consent - Age ≥ 18 years - Patients with previously untreated DLBCL who are scheduled to receive rituximab 375 mg/m^2 plus CHOP chemotherapy, or previously untreated follicular NHL who are scheduled to receive rituximab 375 mg/m^2 plus CVP chemotherapy Exclusion Criteria: - Clinically significant cardiovascular disease (e.g., uncontrolled hypertension, myocardial infarction, unstable angina), New York Heart Association (NYHA) Classification Grade II or greater congestive heart failure, a ventricular arrhythmia requiring medication within 1 year prior to Day 1, or NYHA Grade II or greater peripheral vascular disease on Day 1 Patients who meet any of the following criteria will be excluded from further study participation after Cycle 1: - Circulating lymphocyte count >5,000/μL before the Cycle 2 Rituximab infusion - Development of a serious and/or Grade 3 or 4 adverse event during Cycle 1 judged by the investigator to be related to the rituximab infusion
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.